The Effects of Elmore Oil on Patients With Osteoarthritis

Completed

• Conditions: Degenerative Arthritis; Inflammation

• Registration Number: NCT01684371
• Lead Sponsor: Elmore Oil Company Pty Ltd

Brief Summary

The treatment of osteoarthritis, a disease that eventually affects the majority of the older population, involves the alleviation of symptoms such as pain and stiffness, and the reduction of inflammation. A double-blind, placebo-controlled, crossover study will be performed to examine the effect of topical application of Elmore Oil, a herbal remedy (containing Eucalyptus oil, Tea tree oil, Olive oil and Vanilla), which has recently been reported to have anti-inflammatory properties, on the symptoms of osteoarthritis.

Detailed Description

Sixty patients were randomly selected and approved for the study, 30 patients with even numbers received the blue dotted Elmore oil and 30 patients with odd numbers got the orange dotted Elmore and were advised to apply 3x daily on the affected knees respectively for four weeks. On the fifth week, they stopped application for 7 days as flush out period. Then on the 6th week a cross over was done on the patients - the blue dotted patients, this time received the orange dotted Elmore Oil and vice-versa and did the application three times daily for another 4 weeks. All throughout the usage, they filled out their diaries (noting the degree of pain, feeling of well being (improved sleep, mobility, ability to do their daily activities at home or at work). A pre-application base line laboratory tests were done, after 4 weeks and after 8 weeks.

Study Timeline

• Study Start: 2008-11
• Primary Completion: 2009-04
• Study First Submitted: 2009-04-22
• Study Completion: 2009-06
• Status Verified: 2012-09
• Study First Submitted QC: 2012-09-10
• Last Update Submitted: 2012-09-10
• Study First Posted: 2012-09-13
• Last Update Posted: 2012-09-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Diagnosed osteoarthritis based on the criteria developed by the American College of Rheumatology.

Exclusion Criteria

• Using other forms of topical pain relief.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease in joint swelling, pain and stiffness after each treatment period	Every day for 28 days

Secondary Outcome Measures

Name	Time	Method
Detect changes in Full Blood Examination parameters, liver function tests, and kidney function tests, including a CRP and ESR.	28 days

Trial Locations

Locations (1)

Veterans Memorial Medical Centre; 🇵🇭 Quezon City, Manila, Philippines